Pneumococcal Vaccine Market Opportunities Emerging from Increasing Healthcare Expenditure and Growing Focus on Infectious Disease Prevention
According to a new report by Polaris Market Research, the global pneumococcal vaccine market was valued at USD 9.16 billion in 2025 and is projected to reach USD 14.57 billion by 2034, expanding at a CAGR of 5.30% over the forecast period. Growth is underpinned by rising incidence of pneumococcal disease across age groups, expanding government-backed immunization programs, and...
0 Commentaires 0 Parts 12 Vue 0 Aperçu